1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
A Standard patent application filed on 11 June 2003 credited to Pennell, Andrew M. K.
;
McMaster, Brian E.
;
Dairaghi, Daniel Joseph
;
Martichonok, Valeri V.
;
Aggen, James B.
;
Sen, Subhabrata
;
Wright, J. J. Kim
Details
Application number :
2003236500
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
1-aryl-4-substituted piperazine derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
Inventor :
Pennell, Andrew M. K.
;
McMaster, Brian E.
;
Dairaghi, Daniel Joseph
;
Martichonok, Valeri V.
;
Aggen, James B.
;
Sen, Subhabrata
;
Wright, J. J. Kim
Agent name :
Spruson & Ferguson
Address for service :
Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia
Filing date :
11 June 2003
Associated companies :
Applicant name :
Chemocentryx, Inc.
Applicant address :
1539 Industrial Road San Carlos CA 94070 United States of America